Newsroom > Articles

2023.01

The European Cancer Imaging Initiative aims to advance innovation and deployment of digital technologies in cancer treatment and care, to achieve more precise and faster clinical decision-making, diagnostics and treatments. The European Cancer Imaging Initiative is one of the flagships of the EBCP, Europe’s Beating Cancer Plan, which endeavors to make the most of the potential of data and digital technologies such as AI and High-Performance Computing to fight cancer.

Medexprim is proud to participate to such an ambitious initiative fostering predictive medicine for cancer patients: its cornerstone will be a federated European infrastructure for cancer images data, developed by the EUCAIM multicentric project. 

More information on the European Commission website

Read the European Commission’s Press Release

3 questions to Coralie Carron

As a Ph.D. holder in Cellular and Molecular Biology, Coralie Carron assumes the pivotal…

CIAN: Cohort Imaging Analytics Network

Medexprim enables the aggregation, curation and enrichment of multicentric and multimodal cohorts of Real-World…

šŸ’”Scientific Insights – Read Samuel Boucher’s Take on the future…

Medexprim’s researchers and engineers contribute daily to the advancement of scientific research. Our researchers…

PR – Medexprim partners with Avicenna.AI to help validate their…

Medexprim, the European leader in multimodal Real-World datasets for clinical research, is pleased to…